Schrödinger, Inc. (NASDAQ:SDGR) Receives $32.29 Consensus PT from Analysts

Shares of Schrödinger, Inc. (NASDAQ:SDGR) have been given an average recommendation of “Buy” by the eight research firms that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $32.29.

Several analysts recently commented on the company. KeyCorp raised their target price on Schrödinger from $25.00 to $27.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Piper Sandler cut their target price on shares of Schrödinger from $50.00 to $45.00 and set an “overweight” rating for the company in a report on Thursday, February 27th.

Schrödinger Trading Down 1.1 %

SDGR opened at $19.74 on Thursday. Schrödinger has a 12-month low of $16.67 and a 12-month high of $29.15. The firm has a 50 day moving average of $23.12 and a two-hundred day moving average of $20.78. The firm has a market capitalization of $1.44 billion, a PE ratio of -8.44 and a beta of 1.62.

Schrödinger (NASDAQ:SDGR) last posted its quarterly earnings results on Wednesday, February 26th. The company reported ($0.55) EPS for the quarter, missing the consensus estimate of ($0.35) by ($0.20). The business had revenue of $88.32 million during the quarter, compared to analysts’ expectations of $83.20 million. Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. As a group, analysts predict that Schrödinger will post -2.37 EPS for the current fiscal year.

Insider Activity

In related news, CFO Geoffrey Craig Porges sold 5,491 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $21.76, for a total value of $119,484.16. Following the completion of the transaction, the chief financial officer now directly owns 27,544 shares of the company’s stock, valued at approximately $599,357.44. This represents a 16.62 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 8.60% of the company’s stock.

Institutional Investors Weigh In On Schrödinger

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. United Advisor Group LLC boosted its holdings in shares of Schrödinger by 3.3% during the 4th quarter. United Advisor Group LLC now owns 19,769 shares of the company’s stock worth $381,000 after purchasing an additional 634 shares during the last quarter. Two Sigma Advisers LP acquired a new position in Schrödinger during the fourth quarter worth $473,000. Two Sigma Investments LP purchased a new stake in Schrödinger in the 4th quarter valued at $1,939,000. Tema Etfs LLC acquired a new stake in shares of Schrödinger in the 4th quarter worth $671,000. Finally, Point72 Hong Kong Ltd purchased a new position in shares of Schrödinger during the 4th quarter worth $27,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

About Schrödinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.